Diabetic Macular Edema Outcomes Compared for Aflibercept, Bevacizumab
Outcomes at two years comparable among patients with diabetic macular edema receiving aflibercept monotherapy, bevacizumab first
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.